1. Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness
   Rinad Mahmoud et al, 2022, Cancers CrossRef
2. High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection
   Attapol Titapun et al, 2021, International Journal of General Medicine CrossRef
3. Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC
   Paola Ferrari et al, 2022, International Journal of Molecular Sciences CrossRef
4. Triple-Negative Breast Cancer: the Current Aspects of Pathogenesis and Therapies
   Shinjit Mani et al, 2022, BioNanoScience CrossRef
5. The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment options
   Arpit Dave et al, 2023, Cellular Oncology CrossRef
6. Novel strategies to target chemoresistant triple-negative breast cancer
   Jaganathan Venkatesh et al, 2020, Genes & Cancer CrossRef
7. The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis
   Lei Xing et al, 2020, Aging CrossRef
8. Cell Differentiation Trajectory-Associated Molecular Classification of Osteosarcoma
   Ankai Xu et al, 2021, Genes CrossRef
9. Ferroptosis as a promising targeted therapy for triple negative breast cancer
   Kasra Mokhtarpour et al, 2024, Breast Cancer Research and Treatment CrossRef
10. Evaluation of CD44+/CD24- and Aldehyde Dehydrogenase Enzyme Markers in Cancer Stem Cells as Prognostic Indicators for Triple-Negative Breast Cancer
    Lisbeth Escudero Mendez et al, 2022, Cureus CrossRef
11. Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine
    Françoise Derouane et al, 2022, Cancers CrossRef
12. EXPRESSION OF CD44 AND CD24 MARKERS IN BIOPSY SAMPLES OF TRIPLE NEGATIVE BREAST CANCER PATIENTS BEFORE TREATMENT
    S. G. Smirnova et al, 2020, Siberian journal of oncology CrossRef
13. Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer
    Xugui Zhao et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
14. Role of Cancer Stem-like Cells in the Process of Invasion and Mesenchymal Transformation by a Reconstituted Triple-negative Breast Cancer Cell Population Resistant to p53-induced Apoptosis
    Sana Inoue et al, 2022, ACTA HISTOCHEMICA ET CYTOCHEMICA CrossRef
15. The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer
    Lin He et al, 2021, Cancers CrossRef
16. A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
    Mahdi Abdoli Shadbad et al, 2021, Frontiers in Oncology CrossRef
17. Analyzing mRNAsi-Related Genes Identifies Novel Prognostic Markers and Potential Drug Combination for Patients with Basal Breast Cancer
    Kai Huang et al, 2021, Disease Markers CrossRef
18. The role of telocytes and miR-21-5p in tumorigenicity and metastasis of breast cancer stem cells
    Sena Babadag et al, 2024, Molecular Biology Reports CrossRef
19. Characteristics of Molecularly Engineered Anticancer Drug Conjugated Organic Nanomicelles for Site-Selective Cancer Cell Rupture and Growth Inhibition of Tumor Spheroids
    Nishant Kumar Jain et al, 2020, ACS Applied Bio Materials CrossRef
20. Integrating Genomic Information with Tumor-Immune Microenvironment in Triple-Negative Breast Cancer
    David Otohinoyi et al, 2022, International Journal of Environmental Research and Public Health CrossRef
21. Breast cancer stem cells: mechanobiology reveals highly invasive cancer cell subpopulations
    Martha B. Alvarez-Elizondo et al, 2022, Cellular and Molecular Life Sciences CrossRef
22. Prevention of breast cancer by dietary polyphenols—role of cancer stem cells
    Hao-Feng Gu et al, 2020, Critical Reviews in Food Science and Nutrition CrossRef